Platform for genetic evaluation of the treatment of patients with tuberculosis or HIV

Project 41

Problem to be solved:
• Drug metabolism associated with adverse reactions
• Inefficient therapy in the different pharmacogenetic profiles

Proposed Innovation:
• Customizing treatment to minimize adverse effects
• Use of molecular tests to identify the pharmacogenetic profile

Differential:
• Based on the individual genetic polymorphism
• Platform validated through more than 200 previously tested patients
• Cost reduction for the Brazilian Health System
• Platform is applicable to various infectious diseases

Development status:
Productive sector of goods and services

Intellectual property status:
No patent protection

What we want
Partnership

Coordinator:
Liane de Castro / INI

Contact:
Gestec/VPPIS – Phone: 21 3882-9099 / 3882-9120 or portfolio@fiocruz.br